Search

everythinglearnresearchcommunity

for

Search:↓

Scientists identified three genes important for processing certain brain chemicals, thyroid hormones, and medications.

Dabrafenib was effective and well tolerated in treating thyroid cancer with a specific mutation.

A mutation in the vitamin D receptor causes severe resistance to vitamin D, affecting bone health but not hair growth.

A reliable method was developed to measure Minoxidil and Tofacitinib in gel for hair loss treatment.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

Group behavior therapy reduces hair-pulling symptoms more than supportive therapy but has limited long-term effectiveness.

ATP helps prevent skin damage from vandetanib by reducing stress.

Blocking a certain signal in the gp130 receptor can improve tissue healing and lessen osteoarthritis symptoms.

The laser system helps study brain cell functions by precisely removing specific cells and observing changes.

Botulinum Toxin Type A effectively treats various conditions with high patient satisfaction and minimal side effects.

Oral tofacitinib may be an effective and tolerable treatment for some people with severe alopecia areata.

Dacomitinib can cause nail and skin issues, but these can be managed without stopping the drug.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

SV40 T antigen in hair follicles causes abnormal hair and health issues in mice.

Hair follicles can help diagnose traumatic brain injury quickly and non-invasively.

Long-standing benign tumors can become cancerous, especially in people with weakened immune systems.

An arthritis drug helped a person with severe hair loss regrow their hair.

CTHRC1 is essential for healing and preventing heart rupture after a heart attack.

A rare skin condition was confirmed to be associated with a specific virus in a young girl.

Light therapy on the brain shows promise for treating brain diseases and improving brain function.

A new genetic mutation in the TRPS1 gene causes Trichorhinophalangeal Syndrome, leading to specific hair, dental, and bone issues.

TP0427736 may help treat hair loss by blocking a specific protein and promoting hair growth.

The combination of high-dose toremifene and capecitabine was effective for advanced recurrent breast cancer.

Compounds from Eclipta prostrata L. plant have diabetes and obesity-fighting properties and reduce inflammation.

TH antibodies in vitiligo and AA patients recognize the same protein parts.

Temozolomide can cause severe bone marrow suppression, leading to life-threatening complications.

A new TP63 mutation was found in a baby with EEC syndrome, showing the need for TREC testing to check for immune issues.

New cancer treatments show promise in reducing tumor growth and improving skin regeneration in mice.

Targeting the TNFRSF1B gene may help treat hair loss.